drug
(chlorpheniramine maleate + ibuprofen + pseudoephedrine hydrochloride)
Marketedupdated 3mo agoby $HLN Haleon plc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 28, 2027
214 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Feb 28, 2027formulationUS 7863287214d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that